Syntheses of a metabolite of the second messenger myo-inositol 1,4,5-trisphosphate, myo-inositol 1,4-bisphosphate, and an analogue, the 1,4-bisphosphorothioate, are reported, by using phosphite chemistry on (± )-1,2: 4,5-di-isopropylidene-myo-inositol. The synthesis of (± )-1,2: 4,5-di-isopropylidene 3,6-bis[di-(2-cyanoethyl)]phosphite provides an intermediate that can be oxidized to either the corresponding bisphosphate or bisphosphorothioate. myo-Inositol phosphorothioates are proposed as novel analogues of myo-inositol phosphates; their resistance to phosphatase-catalysed breakdown is reported. and myo-inositol 1,3,4,5-tetrakisphosphate [4, 5] . The latter has been proposed as a second messenger regulating Ca2" entry into the cell [6] . These discoveries have refocused much biological interest on the inositol phosphates [7, 8] . The isolation of such compounds from natural sources is often tedious and difficult [9] , and on account of this it is important to develop synthetic approaches to the natural compounds [10] [11] [12] and analogues with novel biological properties. We have developed an approach using phosphite chemistry, and have reported syntheses of myo-inositol 4,5-bisphosphate [13, 14] and biologically active myo-inositol 1,4,5-trisphosphate [15, 16] . We now report the synthesis of a metabolite of the latter, myo-inositol 1,4-bisphosphate [17] , and an analogue thereof, myo-inositol 1,4-bisphosphorothioate, which we introduce as an example of new analogues of myo-inositol phosphates and demonstrate that such compounds have the novel property of resistance to phosphatase-catalysed breakdown, an important process in second-messenger deactivation and metabolism.
INTRODUCTION
D-myo-Inositol 1,4,5-trisphosphate [(I) in Fig. 1 ], derived from the hexitol myo-inositol [(II) in Fig. 1 ], is released by receptor-stimulatedphosphodiesteratic hydrolysis of the membrane lipid phosphatidylinositol 4,5-bisphosphate, and has been recently identified as an intracellular second messenger mediating calcium mobilization from non-mitochondrial ATP-dependent stores [1, 2] . Additionally, other related inositol phosphates have been reported: myo-inositol 1,3,4-trisphosphate [3] and myo-inositol 1,3,4,5-tetrakisphosphate [4, 5] . The latter has been proposed as a second messenger regulating Ca2" entry into the cell [6] . These discoveries have refocused much biological interest on the inositol phosphates [7, 8] . The isolation of such compounds from natural sources is often tedious and difficult [9] , and on account of this it is important to develop synthetic approaches to the natural compounds [10] [11] [12] and analogues with novel biological properties. We have developed an approach using phosphite chemistry, and have reported syntheses of myo-inositol 4,5-bisphosphate [13, 14] and biologically active myo-inositol 1,4,5-trisphosphate [15, 16] . We now report the synthesis of a metabolite of the latter, myo-inositol 1,4-bisphosphate [17] , and an analogue thereof, myo-inositol 1,4-bisphosphorothioate, which we introduce as an example of new analogues of myo-inositol phosphates and demonstrate that such compounds have the novel property of resistance to phosphatase-catalysed breakdown, an important process in second-messenger deactivation and metabolism.
Chemical Co. as a suspension in 3.2 M-(NH4)2SO4/ 1 mM-MgCl2/0.1 mM-ZnCl2, pH 7, activity 1060 units (,umol/min)/mg of protein at pH 10.4 at 37°C with p-nitrophenyl phosphate as substrate.
General methods
Ion-exchange chromatography was performed on columns of DEAE-Sephadex A-25 (HCO3 form) with linear gradients of triethylammonium bicarbonate generated by gravity mixing. The column was attached to an LKB Ultrorac 7000 fraction collector.
Phosphate assays carried out on the fractions and to quantify the final product were performed as described by Fiske & SubbaRow [20] . Synthesis of (± )-myo-inositol 1,4-bisphosphate (Vlla) (Scheme 1) (± )-1,2: 4,5-Di-isopropylidene-myo-inositol (III) [18] (0.325 mmol) was allowed to react with di-isopropylamino-(2-cyanoethoxy)chlorophosphine (0.715 mmol) and di-isopropylethylamine (0.715 mmol) in dichloromethane for 1 [18] . Di-isopropylamino-(2-cyanoethoxy)chlorophosphine was prepared as described by Sinha et al. [19] . t-Butyl hydroperoxide (3 M -bisphosphorothioate were observed, on account of the two chiral phosphorus centres (intensity ratios, downfield pair/upfield pair, approx 2:1). Reaction of the bisphosphoramidite with tetrazole and 2-cyanoethanol (0.715 mmol of each) gave the bisphosphite triester (V) [8, Vol. 246 spectrum could be seen when monitored over a few hours, and after overnight incubation (23 h) the spectrum showed only the two peaks assignable to the bisphosphorothioate.
RESULTS
(± )-myo-inositol 1,4-bisphosphate (VIIa) and 1,4-bisphosphorothioate (VIIb) were synthesized from (±)-1,2:4,5-di-isopropylidene-myo-inositol (III) by using a phosphite approach. Incubation of the 1,4-bisphosphate with alkaline phosphatase resulted in breakdown to myoinositol and inorganic phosphate, as monitored by 31P-n.m.r. spectroscopy. Under the same conditions the 1,4-bisphosphorothioate was not hydrolysed.
DISCUSSION
It is clear that second-messenger molecules must be rapidly degraded after they have achieved their function, in order to return the system to its basal state. This task is carried out in the case of myo-inositol 1,4,5-trisphosphate primarily by phosphatase action. Thus analogues of inositol phosphates wherein receptor-and enzymebinding properties were similar, but which were resistant to such phosphatase-catalysed breakdown, might be expected to show novel biological properties and facilitate investigation of the metabolism of the 1,4,5-trisphosphate. Replacement of a phosphate group by a phosphorothioate could markedly influence the lifetime of such a second messenger and its metabolites, without greatly affecting their affinity for receptors or enzymes. Phosphorothioate analogues of nucleotides have been found to be extraordinarily useful in applications ranging from studies on the mechanism of phosphoryl-and nucleotidyl-transfer reactions to molecular biology [22, 23] . A phosphorothioate analogue adenosine 3',5'-cyclic phosphorothioate has also found useful applications in the cyclic AMP second-messenger signalling system [22, 23] . One important feature of these analogues is that phosphorothioate monoesters such as adenosine 5'-phosphorothioate, for example, show resistance to phosphatases [24, 25] . This can lead to novel effects. For example, glycogen phosphorylase a is frozen in the active conformation because of phosphatase-resistance when produced by thiophosphorylation of phosphorylase b with adenosine 5'-O-(3-thiotriphosphate) [26] .
D-myo-Inositol 1,4-bisphosphate has recently been identified as a metabolite of the second messenger Dmyo-inositol 1,4,5-trisphosphate in stimulated cells. Its formation is thought to occur by the action of a specific 5-phosphatase located in the cellular plasma membrane and in the cytosol [27] . Such a 5-phosphomonoesterase has been isolated and purified from human platelets [28] . Subsequent phosphatase action converts this 1,4-bisphosphate into myo-inositol, which then re-enters the lipid cycle. The other route of metabolism appears to be phosphorylation to the 1,3,4,5-tetrakisphosphate and subsequent dephosphorylation via the 1,3,4-trisphosphate to myo-inositol [5] . myo-Inositol 1,4-bisphosphate was first synthesized some years ago, before the current interest had developed [17] . We demonstrate here a synthesis of this molecule based upon modern phosphite chemistry, primarily developed for DNA synthesis [19] , and recently adapted by us to the inositol field [13] [14] [15] [16] .
Phosphitylation of compound (III) yields the bisphosphoramidite (IV), which is converted into the bisphos-phite triester (V) {whereas a 5Jpp spin-spin coupling was observed in the 31P-n-.m.r. spectrum of the vicinal 5,6-bisphosphite triester of 1,2,3,4-tetra-0-benzyl-myo-inositol [13, 14] , no corresponding 7J, coupling was observed for compound (V)}. This key intermediate can be oxidized to the bisphosphate triester (VIa) by using t-butyl hydroperoxide or to the bisphosphorothioate triester (VIb) by using sulphur in pyridine. Subsequent removal of the 2-cyanoethyl groups by base-catalysed fl-elimination and acid-catalysed removal of the isopropylidene groups yields either (±)-myo-inositol 1,4-bisphosphate (VIla) or (± )-myo-inositol 1 ,4-bisphosphorothioate (VIIb). This use of P(III) chemistry would provide a route to the-potentially valuable-radioactive 35S-labelled inositol phosphorothioates by oxidation with 35S-labelled sulphur.
We thus undertook the synthesis of an inositol phosphorothioate, and propose the 1,4-bisphosphorothioate here as the first example of these novel nonhydrolysable analogues of inositol phosphates. We expect that inositol phosphorothioates will prove to be of significant value in future studies of the action of inositol phosphate second messengers and their metabolism.
